XM does not provide services to residents of the United States of America.

Dollar holds gains while investors parse China's stimulus plans



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>FOREX-Dollar holds gains while investors parse China's stimulus plans</title></head><body>

Updates prices

By Vidya Ranganathan

SINGAPORE, Oct 14 (Reuters) -The dollar held onto its gains and even extended some in Asian trading on Monday as a holiday in Japan sapped liquidity, leaving China's somewhat disappointing weekend stimulus announcements the focus of market attention.

The euro was down 0.13% at $1.0922 EUR=EBS and the pound was listless but fell 0.2% at one point GBP=D3. The dollar was up 0.13% against the Japanese yen at 149.2750 JPY=EBS.

The dollar index =USD was just above 103 and closing in on last week's peak, its highest since mid-August, on the back of traders reducing bets on further jumbo rate cuts by the Federal Reserve at its remaining meetings this year.

China's yuan CNH= was down 0.2% against the dollar, while the Aussie AUD=D3, whose fortunes are closely tied to China, was down 0.16% at $0.67385.

China said on Saturday it will "significantly increase" government debt issuance to offer subsidies to people with low incomes, support the property market and replenish state banks' capital as it pushes to revive sputtering economic growth.

Without providing details on the size of the fiscal stimulus being prepared, Finance Minister Lan Foan told a press conference there will be more "counter-cyclical measures" this year.

"Markets are likely disappointed that China's Finance Ministry did not unveil concrete additional stimulus," said Richard Franulovich, head of FX strategy at Westpac, in a note.

"The weekend press briefing mostly just reinforces our existing expectations that China's policy pivot is worth a one-time 3-4 cents lift in the Australian dollar's equilibrium, of which about half has already been priced in."

Further moves are unlikely, he said, until there is progress toward addressing excess housing, local government debt and demographic challenges as China's population ages.

The onshore yuan CNY=CFXS is down 0.7% against the dollar since Sept. 24, when the People's Bank of China kicked off China's most aggressive stimulus measures since the pandemic.

The CSI300 Index .CSI300 has broken records for daily moves and is up 18% overall. But stocks have grown wobbly in recent sessions as initial enthusiasm about economic stimulus gave way to concerns about whether the policy support would be big enough to revive growth.

"More time may be needed for more thought-out and targeted measures," said Christopher Wong, currency strategist at OCBC in Singapore. "But those measures also need to come fast as markets are eagerly waiting for them. Over expectations vs under-delivery would result in disappointment..."

Currency moves in major markets were tepid last week. The yen and euro both fell around 0.3% each, sterling shed 0.4% and the dollar index climbed 0.4%.

U.S. Treasuries are unlikely to provide much of a lead on Monday, since both Japan and the U.S. markets are closed for holidays.

Last week's U.S. data showing slightly hotter-than-expected consumer inflation but also higher weekly jobless claims have left intact expectations for the Fed to cut rates by 25 basis points in November and December.

Traders next have on their radar Thursday's retail sales and jobless claims data in the United States, and a policy review by the European Central Bank.

Fed Governor Christopher Waller speaks later on Monday. He is one of the voices who supports a larger rate cut because he is now worried the pace of price increases is undershooting the Fed's target.

The New Zealand dollar NZD=D3 was down 0.15% at $0.61, following last week's 0.8% drop after the central bank slashed rates by a half point and hinted at further cuts to come.

Singapore's central bank kept its currency-based monetary policy steady on Monday.



Reporting by Vidya Ranganathan in Singapore; Editing by Jamie Freed

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.